VERSAVO 400MG INJECTION 16 ML

VERSAVO 400MG INJECTION 16 ML is a recombinant monoclonal antibody that belongs to the immunotherapy class of cancer treatment. It can either be used as monotherapy or in combination with chemotherapy or immunotherapy medications to improve the overall survival rate.

While for women with reproductive potential subjected to VERSAVO 400MG INJECTION 16 ML, it is advised to discuss with your doctor regarding the effective birth control methods during the treatment. Also to be continued for a minimum of 6 months after the treatment course completion as this medicine may impair fertility.

VERSAVO 400MG INJECTION 16 ML is associated with increased risk of bleeding complications and poor wound healing. Hence it is suggested to avoid planning for surgery and maintain an interval of 28days before or after surgery.

All the side effects that are relatively caused by VERSAVO 400MG INJECTION 16 ML occur until the drug concentration stays in the body. It is found that this medicine will be contained in our body for almost 4 months after the final dose.

VERSAVO 400MG INJECTION 16 ML is given intravenously through infusion and the amount of drug will be measured based on the patient’s body weight, height and age. The first dose will be administered for 90 minutes and if well tolerated the infusion time can be reduced to 30 minutes.

Inform your physician before starting your treatment with VERSAVO 400MG INJECTION 16 ML in case, if you are pregnant or planning for pregnancy as this medicine may cause harm to the unborn baby and interrupt the formation of blood vessels.

It is important to inform your doctor about all other medicines you are taking, including prescription, over-the-counter, vitamins, and herbal products, as VERSAVO 400MG INJECTION 16 ML may interact with them. Your doctor will assess potential interactions.

Before starting VERSAVO 400MG INJECTION 16 ML, it is vital to inform your physician if you have conditions involving inflammation in the stomach (ulcer, colitis), experience allergic reactions to VERSAVO 400MG INJECTION 16 ML or its ingredients, have recently undergone surgery, or have diabetes, hypertension, or heart problems.

The active molecule in VERSAVO 400MG INJECTION 16 ML is Bevacizumab.

VERSAVO 400MG INJECTION 16 ML is primarily used in the treatment of various types of cancer.

VERSAVO 400MG INJECTION 16 ML works by blocking the growth of new blood vessels that cancer cells need to grow and spread. This helps to slow down the growth and progression of the tumor.